Search research articles
Contact Us
Filters
Showing results (211-220 of 272) with videos related to
Page
of 28
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2015
Intracellular delivery system for antibody-Peptide drug conjugates
Geoffrey Y Berguig, Anthony J Convertine, Shani Frayo, et al.
Cancer Immunology Research
|
May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab
Gregory A Rufener, Oliver W Press, Philip Olsen, et al.
Bone Marrow Transplantation
|
September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
W I Bensinger, P S Becker, T A Gooley, et al.
Blood
|
March 9, 2013
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
Johnnie J Orozco, Tom Bäck, Aimee Kenoyer, et al.
Journal of Cancer Survivorship : Research and Practice
|
July 14, 2016
Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208
Carol M Moinpour, Joseph M Unger, Patricia A Ganz, et al.
Plos One
|
December 3, 2014
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model
Johnnie J Orozco, Ethan R Balkin, Ted A Gooley, et al.
Blood Advances
|
October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
Victor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood
|
September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
John M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica
|
October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia
Phuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Cancer Research
|
June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas
Shyril O'Steen, Damian J Green, Ajay K Gopal, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 272) with videos related to
Sort By:
Page
of 28
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2015
Intracellular delivery system for antibody-Peptide drug conjugates
Geoffrey Y Berguig, Anthony J Convertine, Shani Frayo, et al.
Cancer Immunology Research
|
May 20, 2016
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab
Gregory A Rufener, Oliver W Press, Philip Olsen, et al.
Bone Marrow Transplantation
|
September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
W I Bensinger, P S Becker, T A Gooley, et al.
Blood
|
March 9, 2013
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
Johnnie J Orozco, Tom Bäck, Aimee Kenoyer, et al.
Journal of Cancer Survivorship : Research and Practice
|
July 14, 2016
Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208
Carol M Moinpour, Joseph M Unger, Patricia A Ganz, et al.
Plos One
|
December 3, 2014
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model
Johnnie J Orozco, Ethan R Balkin, Ted A Gooley, et al.
Blood Advances
|
October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
Victor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood
|
September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
John M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Haematologica
|
October 5, 2019
Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia
Phuong Vo, Ted A Gooley, Joseph G Rajendran, et al.
Cancer Research
|
June 2, 2017
Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas
Shyril O'Steen, Damian J Green, Ajay K Gopal, et al.
Page
of 28